業(yè)執(zhí)照.jpg)
柴胡皂苷D
分析標(biāo)準(zhǔn)品,HPLC≥98%
Saikosaponian D
CAS號(hào)：20874-52-6
分子式：C42H68O13
分子量：780.98
MDL：MFCD09028095
別名：柴胡皂苷 D;Saikosaponin BII; Saikosaponin b2 std.; Saikosaponian D; SAIKOSAPONINB2STANDARD; SaikosaponinD; (3β,4α,16α)-13,28-Epoxy-16,23-dihydroxyolean-11-en-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-β-D-galact
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20150-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥900.00 | 現(xiàn)貨 |
YJ-B20150-200mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥2500.00 | 現(xiàn)貨 |
A10268-20mg | 分析標(biāo)準(zhǔn)品,含量96.5%，可溯源 | ￥1700.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：256- 259℃
沸點(diǎn)：893.7℃ at 760 mmHg
比旋光度：(EtOH)+37
外觀：白色粉末
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶(hù)參考交流研究之用。
參考文獻(xiàn)(44篇)
44. [IF=5.4] Lihua Cui et al."Hu Gan Tang ameliorates metabolic-associated fatty liver disease by inhibiting ferroptosis through the Nrf2/GPX4 pathway."JOURNAL OF ETHNOPHARMACOLOGY.2025 Sep;353:120342
43. [IF=4.8] Li Fang et al."Insights into infraspecific differentiation of the medicinally important species Bupleurum Chinense revealed by morphological and molecular evidence."BMC PLANT BIOLOGY.2025 Dec;25(1):1-13
42. [IF=4.3] Zhang Wenli et al."Evaluation of different ecological regions for cultivation of best quality Bupleurum: a case study from Shanxi, China."BMC PLANT BIOLOGY.2025 Dec;25(1):1-14
41. [IF=14.7] Wenxiang Hong et al."Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis."Acta Pharmaceutica Sinica B.2025 Feb;:
40. [IF=4.1] Shengwei Zhou et al."Suitable concentrations of brassinolide application enhances growth performance and saikosaponin biosynthesis by transcriptional activation of triterpenoid pathway genes in Bupleurum chinense DC."Frontiers in Plant Science.2025 Mar;16
39. [IF=3.4] Guangjie Liu et al."Transcriptome analysis revealing the effect of Bupleurum scorzonerifolium Willd association with endophytic fungi CHS3 on the production of saikosaponin D."Heliyon.2024 Jun;10:
38. [IF=5.4] Ruolan Sun et al."Homotherapy-for-heteropathy of Bupleurum Chinense DC.-Scutellaria baicalensis Georgi in treating depression and colorectal cancer: A network pharmacology and animal model approach."JOURNAL OF ETHNOPHARMACOLOGY".2024 Mar;:118038
37. [IF=3.4] Tongtong Yang et al."Combination of histological and metabolomic assessments to evaluate the potential pharmacological efficacy of saikosaponin D."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS".2024 May;242:116001
36. [IF=5.4] Liangxin Zhao et al."UPLC-Q-Exactive/MS based analysis explore the correlation between components variations and anti-influenza virus effect of four quantified extracts of Chaihu Guizhi decoction."JOURNAL OF ETHNOPHARMACOLOGY.2023 Oct;:117318
35. [IF=4.6] Zhenhuan Wang et al."Quantitative and Differential Analysis between Bupleurum chinense DC. and Bupleurum scorzonerifolium Willd. Using HPLC-MS and GC-MS Coupled with Multivariate Statistical Analysis."MOLECULES.2023 Jan;28(15):5630
34. [IF=2.838] Xu Manman et al."Kaixin Jieyu Granule attenuates neuroinflammation-induced depressive-like behavior through TLR4/PI3K/AKT/FOXO1 pathway: a study of network pharmacology and experimental validation."BMC Complementary Medicine and Therapies.2023 Dec;23(1):1
33. [IF=4.141] Yiqing Peng et al."Assessment of Genetic Diversity in Bupleurum spp. Basing Agronomic Traits, Medicinal Components and ISSR Markers."Genes.2023 Apr;14(4):951
32. [IF=6.656] Minna Huang et al."Saikosaponin A and D attenuate skeletal muscle atrophy in chronic kidney disease by reducing oxidative stress through activation of PI3K/AKT/Nrf2 pathway."PHYTOMEDICINE.2023 Jun;114:154766
31. [IF=3.246] Guimei Liu et al."Saikosaponin D Inducing Apoptosis and Autophagy through the Activation of Endoplasmic Reticulum Stress in Glioblastoma."Biomed Research International.2022 Nov 24;2022:5489553
30. [IF=3.369] Li Liu et al."Effects of Trichoderma harzianum biofertilizer on growth, yield, and quality of Bupleurum chinense."Plant Direct.2022 Nov;6(11):e461
29. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199
28. [IF=4.927] Linlin Yang et al."Drought Stress Stimulates the Terpenoid Backbone and Triterpenoid Biosynthesis Pathway to Promote the Synthesis of Saikosaponin in Bupleurum chinense DC. Roots."MOLECULES.2022 Jan;27(17):5470
27. [IF=3.911] Du Jikun et al."Saikosaponin-D Mitigates Oxidation in SH-SY5Y Cells Stimulated by Glutamate Through Activation of Nrf2 Pathway: Involvement of PI3K."Neurotox Res. 2022 Jan;:1-11
26. [IF=2.45] Li Shengyun et al."Establishment and Application of a Method for the Determination of Ganoderic Acid A."J Food Quality. 2020;2020:6621853
25. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950
24. [IF=3.205] Jie Tang et al."Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry."J Chromatogr B. 2021 Aug;1179:122827
23. [IF=3.337] Mengru Lai et al."Saikosaponin D Inhibits Proliferation and Promotes Apoptosis Through Activation of MKK4–JNK Signaling Pathway in Pancreatic Cancer Cells."Oncotargets Ther. 2020; 13: 9465–9479
22. [IF=3.375] Tian Gao et al."Use of Saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells."Am J Transl Res. 2019; 11(4): 2070–2080
21. [IF=4.36] Xiaojing Zhang et al."A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway."J Ethnopharmacol. 2022 Jan;283:114742
20. [IF=5.81] Cui Lihua et al."Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway."Front Pharmacol. 2021 Jun;0:1369
19. [IF=3.205] Min He et al."Simultaneous determination of multiple bioactive components of Bu-zhong-yi-qi-tang in rat tissues by LC–MS/MS: Application to a tissue distribution study."J Chromatogr B. 2017 Feb;1044-1045:177
18. [IF=3.396] Shi Weiwei et al."Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ–AMPK–mTOR pathway in ADPKD cells."Mol Cell Biochem. 2018 Dec;449(1):219-226
17. [IF=4.396] Xiaoman Chen et al."Synergetic and Antagonistic Molecular Effects Mediated by the Feedback Loop of p53 and JNK between Saikosaponin D and SP600125 on Lung Cancer A549 Cells."Mol Pharmaceut. 2018;15(11):4974–4984
16. [IF=4.411] Dan-Dan Tian et al."Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats."Molecules. 2016 Jun;21(6):696
15. [IF=4.411] Wei Wang et al."In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism."Molecules. 2016 May;21(5):597
14. Wang, Wei, Dan-Dan Tian, and Zhang-Jin Zhang. "In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism." Molecules 21.5 (2016): 597.https:##doi.org/10.3390/molecules21050597
13. Tian D-D, Wang W, Wang H-N, Sze SCW, Zhang Z-J. Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats. Molecules. 2016; 21(6):696. https:##doi.org/10.3390/molecules
12. 敏,王猛猛,吳雨,陳文文,王之通,張磊陽(yáng),蔣健.補(bǔ)中益氣湯6個(gè)成分在大鼠體內(nèi)的藥代動(dòng)力學(xué)研究[J].遼寧中醫(yī)雜志,2020,47(11):159-163.
11. 楊夢(mèng)玲, 尤朋濤, 何麗珊,等. 基于UPLC-MS/MS分析胃潰瘍模型大鼠口服加味小柴胡顆粒后血漿中8種有效成分的藥代動(dòng)力學(xué)[J]. 中國(guó)中藥雜志, 2018, 43(18).
10. 趙昕彤, 辛國(guó), 辛宇,等. 煎煮時(shí)間對(duì)柴胡中柴胡皂苷A和柴胡皂苷D含量的影響[J]. 人參研究, 2017.
9. 廖念, 龐雪, 周逸群,等. 正交試驗(yàn)法優(yōu)選北柴胡麩炒工藝[J]. 中國(guó)藥師, 2017, 020(004):738-740.
8. 曹雪, 蔡廣知, 趙凌,等. 基于復(fù)合質(zhì)量常數(shù)的北柴胡飲片等級(jí)評(píng)價(jià)[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2018(18).
7. 李英, 焦倩, 張?zhí)焯?/span>,等. 基于地形因子的河北省北柴胡生態(tài)適宜性區(qū)劃研究[J]. 中國(guó)中藥雜志, 2017, 042(022):4402-4407.
6. 廖念 龐雪 周逸群 等. 北柴胡麩煨工藝的正交試驗(yàn)法優(yōu)選[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥 2017(05):96-98.
5. 龐雪 廖念 周逸群 等. 不同炮制方法對(duì)北柴胡中柴胡皂苷含量的影響[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥 2016(12):2906-2908.
4. 寧艷梅 楊秀娟 陳暉 張金保 楊韜 任遠(yuǎn).不同比例鱉血炮制柴胡制品中柴胡總皂苷含量測(cè)定與比較[J].中獸醫(yī)醫(yī)藥雜志 2019 38(05):9-13.
3. 辛國(guó) 趙昕彤 李文 等. 不同時(shí)間煎煮柴胡對(duì)五柴胡飲中柴胡皂苷含量及藥效學(xué)的影響[J]. 長(zhǎng)春中醫(yī)藥大學(xué)學(xué)報(bào) 2018(4):641-644.
2. 張娜, 晏旎, 周蒙恩,等. 柴胡皂苷d對(duì)氧化應(yīng)激誘導(dǎo)的人肝星狀細(xì)胞活化后ROS形成及NLRP3炎性小體表達(dá)的影響[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥, 2020(4):805-809.
1. 程玉鵬, 王洪月, 高寧,等. 柴胡與其內(nèi)生真菌共培養(yǎng)的內(nèi)生真菌中柴胡總皂苷含量測(cè)定[J]. 化學(xué)工程師, 2018, v.32;No.279(12):23-25.
從2011年開(kāi)始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶(hù)各類(lèi)實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十余年，是客戶(hù)您值得信賴(lài)的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
